Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis
{{output}}
Background: Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for monitoring treatment response and predicting outcomes in cancer. This meta-analysis aimed to evaluate the prognostic value of ctDNA in predicting ... ...
